MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Sonde Health Partners with GN Group to Research and Develop New Vocal Biomarker Technology to Detect Mild Cognitive Impairment
Mari YoshiokaJanuary 18, 2022
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT

Mari YoshiokaJune 27, 2022
Next

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration

Mari YoshiokaJanuary 5, 2022

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact